Related Experiment Video
Updated: Mar 11, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Update on angiotensin AT2 receptors
1Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA.
New findings reveal angiotensin II (Ang II) subtype 2 receptors (AT2Rs) activation lowers blood pressure and prevents kidney damage. AT2R agonists show promise for cardiovascular and renal diseases.
Area of Science:
- Cardiovascular Science
- Renal Physiology
- Endocrinology
Background:
- The renin-angiotensin system plays a crucial role in regulating blood pressure and fluid balance.
- Angiotensin II (Ang II) exerts its effects through AT1 and AT2 receptors (AT2Rs).
- The specific roles of AT2Rs in cardiovascular and renal function are increasingly recognized.
Purpose of the Study:
- To review recent advancements in understanding the role of AT2Rs in blood pressure and renal function.
- To highlight new findings on AT2R agonists for cardiovascular and renal diseases.
Main Methods:
- Literature review of studies published within the past year.
- Analysis of experimental models of hypertension, obesity, and metabolic syndrome.
- Investigation of molecular mechanisms involving nitric oxide and receptor transcription.
Main Results:
- AT2R activation mitigates sodium retention and reduces blood pressure in experimental hypertension models.
- Des-aspartyl-Ang II (Ang III) is identified as a key AT2R agonist in the kidney and vasculature.
- A novel synthetic Ang III peptide demonstrated vasodepressor effects.
- AT2R activation reduces proteinuria and oxidative stress in kidney disease models.
- A potential positive feedback loop involving nitric oxide and AT2R transcription was proposed.
Conclusions:
- Recent research clarifies the physiological and pathophysiological significance of AT2Rs.
- AT2R agonists represent a promising therapeutic strategy for cardiovascular and renal conditions.
More Related Videos
07:21Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
Published on: September 28, 2015
09:51Live Cell Imaging and 3D Analysis of Angiotensin Receptor Type 1a Trafficking in Transfected Human Embryonic Kidney Cells Using Confocal Microscopy
Published on: March 27, 2017
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Direct Renin Inhibitors
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Antihypertensive Drugs: Action of β1 Blockers
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...